home / stock / crsp / crsp quote
Last: | $53.53 |
---|---|
Change Percent: | -3.81% |
Open: | $53.98 |
Close: | $55.65 |
High: | $54.15 |
Low: | $52.75 |
Volume: | 900,088 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$53.53 | $53.98 | $55.65 | $54.15 | $52.75 | 900,088 | 04-25-2024 |
$55.65 | $56.79 | $55.65 | $57.78 | $55.5 | 913,287 | 04-24-2024 |
$56.41 | $55.93 | $56.41 | $58.675 | $55.56 | 1,186,733 | 04-23-2024 |
$55.66 | $55.4 | $55.66 | $56.93 | $54.37 | 1,044,335 | 04-22-2024 |
$55.05 | $56.16 | $55.05 | $57.5 | $54.275 | 1,766,181 | 04-19-2024 |
$56.16 | $55.86 | $56.16 | $58.0299 | $55.2501 | 1,745,393 | 04-18-2024 |
$55.56 | $58.34 | $55.56 | $58.468 | $55.52 | 1,399,569 | 04-17-2024 |
$57.96 | $58.04 | $57.96 | $58.7381 | $57.14 | 1,176,528 | 04-16-2024 |
$58.72 | $60.74 | $58.72 | $60.95 | $58.47 | 1,468,392 | 04-15-2024 |
$60.67 | $62.23 | $60.67 | $62.35 | $60.25 | 1,079,075 | 04-12-2024 |
$62.91 | $62.69 | $62.91 | $63.08 | $61.32 | 1,040,427 | 04-11-2024 |
$61.74 | $62.1 | $61.74 | $62.93 | $60.31 | 1,981,223 | 04-10-2024 |
$65.19 | $64 | $65.19 | $65.24 | $63.07 | 1,006,234 | 04-09-2024 |
$64.09 | $63.21 | $64.09 | $64.2154 | $62.5113 | 1,123,637 | 04-08-2024 |
$62.9 | $64.4 | $62.9 | $64.4536 | $62.33 | 1,681,496 | 04-05-2024 |
$65.06 | $64.83 | $65.06 | $67.2455 | $64.6706 | 1,220,957 | 04-04-2024 |
$64.6 | $64.73 | $64.6 | $65.4571 | $63.6 | 996,091 | 04-03-2024 |
$65.03 | $66 | $65.03 | $66.39 | $64.26 | 1,499,390 | 04-02-2024 |
$68.18 | $68.145 | $68.18 | $68.389 | $66.5 | 1,078,023 | 04-01-2024 |
$68.16 | $69.98 | $68.16 | $70.12 | $67.52 | 1,603,430 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
CRISPR Therapeutics AG Company Name:
CRSP Stock Symbol:
NASDAQ Market:
ZUG, Switzerland and BOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creat...
ZUG, Switzerland and BOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced an oral presentation highlighting the Company's lipid nanoparticle (LN...
2024-04-20 14:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...